CNIO News -

CNIO Friends
13.06.2023 Nine young scientists will conduct cutting-edge research at CNIO thanks to the solidarity of thousands of donors The excitement of making a discovery and knowing that discovery will help others are truly great...

02.06.2023 A new RNA-based cellular immunotherapy for haematological cancers approaches clinical trials The immunotherapy strategies are based on getting the patient’s own defence cells,...

Members of the multi-stakeholder platform Pancreatic Cancer Europe in the meeting held at CNIO. /Antonio M. Tabernero. CNIO

Events
02.06.2023 Experts in pancreatic cancer in Europe set the roadmap for research into this “forgotten tumor” The incidence of pancreatic cancer is increasing, without any clear reason why. ” It is...

Events
30.05.2023 Genome biology enters the third dimension in search of new treatments If the human genome is ‘the book of life’, its pages are folded into a complex origami figure....

05.05.2023 RENACER, the first collection of live human brain metastasis samples, receives an award from the Spanish Group of Cancer Patients The Spanish Cancer Patients Group (GEPAC) has awarded the “Social and Scientific Research in...

04.05.2023 CNIO Biobank Director Eva Ortega joins the Spanish Science, Technology and Innovation Advisory Council (CACTI) Molecular biochemist Eva Ortega Paíno, Scientific Director of the CNIO Biobank, is one of the new...

Outreach to Society
28.04.2023 The Embassy of Spain in the United States hosts CNIO Arte Since yesterday, the Embassy of Spain in the United States hosts the exhibition Dialogues between...

19.04.2023 Oncologist Richard Vile: “I truly believe that in 10 years’ time oncolytic viruses will be part of effective anti-tumour therapies” Richard Vile is researching oncolytic viruses, which are viruses that specifically attack tumour...

03.04.2023 Claudio Joazeiro: “Our knowledge about protein quality control will lead to new ways to approach cancer, neurodegeneration and aging” Claudio Joazeiro (Brazil, 1968) studies how cells control the quality of their proteins. He wants to...